250 related articles for article (PubMed ID: 24064721)
41. Molecular biology of Pasteurella multocida toxin.
Orth JH; Aktories K
Curr Top Microbiol Immunol; 2012; 361():73-92. PubMed ID: 22371145
[TBL] [Abstract][Full Text] [Related]
42. CXCL8 Knockout: A Key to Resisting
Yuan J; Zhao Q; Li J; Wen Y; Wu R; Zhao S; Lang YF; Yan QG; Huang X; Du S; Cao SJ
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791369
[No Abstract] [Full Text] [Related]
43. Pasteurella multocida.(Preface).
Aktories K; Orth JH; Adler B
Curr Top Microbiol Immunol; 2012; 361():v. PubMed ID: 23230602
[No Abstract] [Full Text] [Related]
44. Intranasal vaccination of New Zealand white rabbits against pasteurellosis, using alginate-encapsulated Pasteurella multocida toxin and potassium thiocyanate extract.
Jarvinen LZ; HogenEsch H; Suckow MA; Bowersock TL
Comp Med; 2000 Jun; 50(3):263-9. PubMed ID: 10894489
[TBL] [Abstract][Full Text] [Related]
45. Pasteurella multocida toxin is a potent activator of anti-apoptotic signalling pathways.
Preuss I; Hildebrand D; Orth JH; Aktories K; Kubatzky KF
Cell Microbiol; 2010 Aug; 12(8):1174-85. PubMed ID: 20331638
[TBL] [Abstract][Full Text] [Related]
46. [Characteristics and immunogenicity of the N-terminal and C-terminal recombinants of Pasteurella multocida toxin].
Tang X; Wu B; Zhao Z; Deng Y; He H; He Q; Chen H
Wei Sheng Wu Xue Bao; 2008 Feb; 48(2):213-9. PubMed ID: 18438004
[TBL] [Abstract][Full Text] [Related]
47. Effects of Pasteurella multocida toxin on the osteoclast population of the rat.
Martineau-Doizé B; Caya I; Gagné S; Jutras I; Dumas G
J Comp Pathol; 1993 Jan; 108(1):81-91. PubMed ID: 8473561
[TBL] [Abstract][Full Text] [Related]
48. Calcineurin-independent inhibition of 3T3-L1 adipogenesis by Pasteurella multocida toxin: suppression of Notch1, stabilization of beta-catenin and pre-adipocyte factor 1.
Aminova LR; Wilson BA
Cell Microbiol; 2007 Oct; 9(10):2485-96. PubMed ID: 17581254
[TBL] [Abstract][Full Text] [Related]
49. Immune responses of piglets to Pasteurella multocida toxin and toxoid.
van Diemen PM; de Vries Reilingh G; Parmentier HK
Vet Immunol Immunopathol; 1994 Jun; 41(3-4):307-21. PubMed ID: 7941310
[TBL] [Abstract][Full Text] [Related]
50. Modulation of host cell gene expression through activation of STAT transcription factors by Pasteurella multocida toxin.
Orth JH; Aktories K; Kubatzky KF
J Biol Chem; 2007 Feb; 282(5):3050-7. PubMed ID: 17150962
[TBL] [Abstract][Full Text] [Related]
51. Mucoadhesive and pH-sensitive thiolated Eudragit microspheres for oral delivery of Pasteurella multocida antigens containing dermonecrotoxin.
Islam MA; Jiang HL; Quan JS; Arote RB; Kang ML; Yoo HS; Yun CH; Choi YJ; Cho CS
J Nanosci Nanotechnol; 2011 May; 11(5):4174-81. PubMed ID: 21780423
[TBL] [Abstract][Full Text] [Related]
52. Effect of Bordetella bronchiseptica and serotype D Pasteurella multocida bacterin-toxoid on the occurrence of atrophic rhinitis after experimental infection with B. bronchiseptica and toxigenic type AP. multocida.
Sakano T; Okada M; Taneda A; Mukai T; Sato S
J Vet Med Sci; 1997 Jan; 59(1):55-7. PubMed ID: 9035080
[TBL] [Abstract][Full Text] [Related]
53. Virulence of Pasteurella multocida in atrophic rhinitis of gnotobiotic pigs infected with Bordetella bronchiseptica.
Rutter JM
Res Vet Sci; 1983 May; 34(3):287-95. PubMed ID: 6878879
[TBL] [Abstract][Full Text] [Related]
54. Protective effect of Pasteurella multocida cell-free antigen and toxoid against challenge with toxigenic strains of pasteurella multocida in mice.
Uchida C; Kimura Y; Kubota S; Sasaki O
J Vet Med Sci; 2003 Jun; 65(6):737-40. PubMed ID: 12867737
[TBL] [Abstract][Full Text] [Related]
55. Characterization of toxin from different strains of Pasteurella multocida serotype A and D.
Frandsen PL; Foged NT; Petersen SK; Bording A
Zentralbl Veterinarmed B; 1991 Jul; 38(5):345-52. PubMed ID: 1927149
[TBL] [Abstract][Full Text] [Related]
56. Genome wide CRISPR screen for Pasteurella multocida toxin (PMT) binding proteins reveals LDL Receptor Related Protein 1 (LRP1) as crucial cellular receptor.
Schoellkopf J; Mueller T; Hippchen L; Mueller T; Reuten R; Backofen R; Orth J; Schmidt G
PLoS Pathog; 2022 Dec; 18(12):e1010781. PubMed ID: 36516199
[TBL] [Abstract][Full Text] [Related]
57. Cytosolic Delivery of Multidomain Cargos by the N Terminus of Pasteurella multocida Toxin.
Clemons NC; Bannai Y; Haywood EE; Xu Y; Buschbach JD; Ho M; Wilson BA
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29784857
[TBL] [Abstract][Full Text] [Related]
58. Pasteurella multocida toxin. The characterisation of the toxin and its significance in the diagnosis and prevention of progressive atrophic rhinitis in pigs.
Foged NT
APMIS Suppl; 1992; 25():1-56. PubMed ID: 1576005
[No Abstract] [Full Text] [Related]
59. Induction of nasal turbinate atrophy in germ-free pigs, using Pasteurella multocida as well as bacterium-free crude and purified dermonecrotic toxin of P multocida.
Kamp EM; Kimman TG
Am J Vet Res; 1988 Nov; 49(11):1844-9. PubMed ID: 3247905
[TBL] [Abstract][Full Text] [Related]
60. [Detection of toxin-producing strains of Pasteurella multocida in nasal and tonsil swabs, a possibility for the control of atrophic rhinitis in swine breeding herds? Parallel comparison with other research methods].
Matschullat G; Müller E; Mumme J; Ikes D
Dtsch Tierarztl Wochenschr; 1994 Jan; 101(1):27-30. PubMed ID: 8131729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
